2019 Annual Meeting | C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment
Program Materials Program Evaluations
03:30 PM - 03:35 PM EDT | Introduction |
Introduction
David S. Knopman, MD, FAAN |
03:35 PM - 04:05 PM EDT | Speaker |
The Clinical Diagnosis of MCI and Dementia Due to AD
Richard J. Caselli, MD, FAAN |
04:05 PM - 04:30 PM EDT | Speaker |
Biomarkers for the Etiological Diagnosis of AD
David S. Knopman, MD, FAAN |
04:30 PM - 04:55 PM EDT | Speaker |
The Role for Genetics in AD Diagnosis and Management
Richard J. Caselli, MD, FAAN |
04:55 PM - 05:15 PM EDT | Speaker |
Therapeutics in AD for 2019
David S. Knopman, MD, FAAN |
05:15 PM - 05:30 PM EDT | Q&A |
Questions and Answers
|
David S. Knopman, MD, FAAN | Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH. |
Richard J. Caselli, MD, FAAN | The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona. |